Effective August 1, 2013, Coronado and Dr. Hehenberger entered into an Amendment to Employment Agreement to appoint Dr. Hehenberger Coronado's Executive Vice President of Scientific Affairs. Dr. Hehenberger previously served as Coronado's Executive Vice President and Chief Medical Officer, from April 19, 2012 to July 31, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | +0.55% | -1.60% | -38.87% |
May. 15 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.87% | 36.65M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Coronado Biosciences, Inc. to Appoint Hehenberger Coronado as Executive Vice President of Scientific Affairs